Updates on Pancreatic Cancer - Highlights from the “48th Annual Pancreas Club Meeting”. Chicago, IL, USA. May 2-3, 2014
DOI:
https://doi.org/10.6092/1590-8577/2509Keywords:
Carcinoma, Pancreas, Pancreatic Neoplasms, Therapeutics /toxicityAbstract
No abstract available.
Image: Chicago view. (From the Program of the "48th Annual Pancreas Club Meeting. Chicago, IL, USA. May 2-3, 2014).
Downloads
References
American Cancer Society. Cancer Facts & Figures 2013. Atlanta, Ga: American Cancer Society; 2013.
Del Chiaro M, Verbeke C, et al. Preliminary Results of a Swedish, MR Based, Screening Program for Individuals at Risk for Pancreas Cancer. Paper presented at the 48th Annual Meeting of the Pancreas Club; May 2014; Chicago, Illinois, USA.
Peng JS et al. Diagnostic Laparoscopy to Detect Occult Metastatic Disease Prior to Neoadjuvant Chemoradiation in Borderline Resectable Pancreatic Ductal Adenocarcinoma - A Cost Analysis. Paper presented at the 48th Annual Meeting of the Pancreas Club; May 2014; Chicago, Illinois, USA.
Lewis RS, Drebin JA, Fraker DL, Vollmer CM. A Comprehensive Assessment of Neoadjuvant Therapy for Pancreatic Adenocarcinoma: Results from the National Cancer Database (NCDB). Paper presented at the 48th Annual Meeting of the Pancreas Club; May 2014; Chicago, Illinois, USA.
Nakeeb A, Parmar A, Riall TS, Kilbane EM, Hall BL, Pitt HA. Minimally Invasic Pancreatoduodenectomy: Is the Learning Curve Surmountable? Paper presented at the 48th Annual Meeting of the Pancreas Club; May 2014; Chicago, Illinois, USA.
Vyas OH, Leung K, Saif MW. Clinical Outcomes in Pancreatic Adenocarcinoma Associated with BRCA2 Mutation. Paper presented at the 48th Annual Meeting of the Pancreas Club; May 2014; Chicago, Illinois, USA.
Lynch, HT, et al. Hereditary Pancreatic Cancer. Pancreatology, 2001; 1(5):466-471.
Iqbal J, Ragone A, Lubinski J, et al. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer.2012;107(12):2005
